Related Experiment Videos
A small-molecule antagonist of virion assembly
1School of Pharmacy, University of Southern California, 1985 Zonal Avenue, Los Angeles, CA 90089, USA. neamati@usc.edu
Expert Opinion on Investigational Drugs
|January 12, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer.
British journal of cancer·2015
Retroviral integrase : a novel target in antiviral drug development and basic in vitro assays with the purified enzyme.
Methods in molecular medicine·2011
An approach to the stereo-controlled synthesis of polycyclic derivatives of l-4-thiazolidinecarboxylic acid active against HIV-1 integrase.
European journal of medicinal chemistry·2006
Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells.
International journal of oncology·2006
Arylisothiocyanate-containing esters of caffeic acid designed as affinity ligands for HIV-1 integrase.
Bioorganic & medicinal chemistry·2001
Discovery of a nuclease-resistant, non-natural dinucleotide that inhibits HIV-1 integrase.
Bioorganic & medicinal chemistry letters·2001
Peripheral cannabinoid-1 receptor antagonists in clinical development: therapeutic potential for the management of obesity and related metabolic disorders.
Expert opinion on investigational drugs·2026
Telisotuzumab adizutecan for metastatic colorectal cancer: a c-MET-targeted antibody-drug conjugate with a topoisomerase inhibitor payload.
Expert opinion on investigational drugs·2026
Taxane therapy in mCRPC: current positioning and emerging strategies to overcome resistance.
Expert opinion on investigational drugs·2026
Receptor interacting protein kinase 1 as a potential therapeutic target in inflammatory bowel disease: biological rationale and emerging clinical evidence.
Expert opinion on investigational drugs·2026
Budigalimab: a viable option for patients with advanced solid tumors.
Expert opinion on investigational drugs·2026
Cognitive-enhancing drugs in Phase II clinical trials for Alzheimer's disease: emerging therapeutic candidates.
Expert opinion on investigational drugs·2026
Two new diastereomeric sterigmatocystin derivatives from the culture broth of Hypomyces sp.
The Journal of antibiotics·2026
Hydroxyl group abundance and lipid environment determine the cytotoxic activity of polyphenols.
Biochemical and biophysical research communications·2026
A streamlined one-pot process for the continuous extraction, biotransformation, and cyclodextrin encapsulation of bioavailable baicalein from Scutellaria baicalensis.
Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Review of promising benzimidazole-based anticancer agents (2023-2026).
Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents·2026
Recent Advances in Camphor-Derived Small-Molecule Organic Fluorescent Probes.
Chemistry (Weinheim an der Bergstrasse, Germany)·2026